News

Medicare adds HPV test for cervical cancer screening


 

References

Medicare officials have added the human papillomavirus test to its list of covered services for cervical cancer screening.

In a national coverage decision issued on July 9, officials at the Centers for Medicare & Medicaid Services announced that the “evidence is sufficient” to add HPV testing once every 5 years as a preventive service benefit under the Medicare program for asymptomatic women aged 30-65 years in conjunction with the Pap smear test.

©xrender/ Thinkstock.com

Previously Medicare only covered a screening pelvic examination and Pap smear test at 12- and 24-month intervals based on specific risk factors.

The decision has the potential to affect about 5 million women aged 30-65 who are enrolled in the Medicare program, according to a CMS estimate.

In 2012, the U.S. Preventive Services Task Force recommended screening with a combination of Pap smear and HPV testing every 5 years for women aged 30-65 years. The task force recommends against using HPV testing for cervical cancer screening in women younger than age 30.

The American Academy of Family Physicians, which had urged Medicare officials to add the HPV test as a covered option for cervical screening, praised the decision.

“This decision is consistent with the best medical evidence and provides women and their physicians more options for cervical cancer screening,” Dr. Robert L. Wergin, AAFP president, said in a statement.

mschneider@frontlinemedcom.com

On Twitter @maryellenny

Recommended Reading

HPV-targeted TILs trigger CR in some advanced cervical cancer patients
MDedge Internal Medicine
Medicare proposes adding HPV screening benefit
MDedge Internal Medicine
New 9-valent HPV vaccine is efficacious, well tolerated
MDedge Internal Medicine
Contamination prompts voluntary injectables recall
MDedge Internal Medicine
ACP recommends cervical screening no more than every 3 years
MDedge Internal Medicine
PAS: Texting beats phone reminders for HPV vaccine completion
MDedge Internal Medicine
ACOG: Long-term low-dose vaginal estrogen poses no apparent cancer risk
MDedge Internal Medicine
ASCO: Precision medicine initiatives take wing
MDedge Internal Medicine
Single HPV vaccine dose appears as effective as full course
MDedge Internal Medicine
EULAR: Women with RA have increased cervical neoplasia rates
MDedge Internal Medicine